<?xml version="1.0" encoding="UTF-8"?>
<crossref_result xmlns="http://www.crossref.org/qrschema/3.0" version="3.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/qrschema/3.0 http://www.crossref.org/schemas/crossref_query_output3.0.xsd">
  <query_result>
    <head>
      <doi_batch_id>none</doi_batch_id>
    </head>
    <body>
      <query status="resolved">
        <doi type="journal_article">10.1093/ijnp/pyw100</doi>
        <crm-item name="publisher-name" type="string">Oxford University Press (OUP)</crm-item>
        <crm-item name="prefix-name" type="string">Oxford University Press</crm-item>
        <crm-item name="member-id" type="number">286</crm-item>
        <crm-item name="citation-id" type="number">86141917</crm-item>
        <crm-item name="journal-id" type="number">6040</crm-item>
        <crm-item name="deposit-timestamp" type="number">2016122218201361000</crm-item>
        <crm-item name="owner-prefix" type="string">10.1093</crm-item>
        <crm-item name="last-update" type="date">2017-08-24T09:57:32Z</crm-item>
        <crm-item name="created" type="date">2016-11-04T04:05:35Z</crm-item>
        <crm-item name="citedby-count" type="number">3</crm-item>
        <doi_record>
          <crossref xmlns="http://www.crossref.org/xschema/1.1" xsi:schemaLocation="http://www.crossref.org/xschema/1.1 http://doi.crossref.org/schemas/unixref1.1.xsd">
            <journal>
              <journal_metadata language="en">
                <full_title>International Journal of Neuropsychopharmacology</full_title>
                <abbrev_title>IJNPPY</abbrev_title>
                <issn media_type="print">1461-1457</issn>
                <issn media_type="electronic">1469-5111</issn>
              </journal_metadata>
              <journal_article publication_type="full_text">
                <titles>
                  <title>The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm</title>
                </titles>
                <contributors>
                  <person_name contributor_role="author" sequence="first">
                    <given_name>Konstantinos N.</given_name>
                    <surname>Fountoulakis</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Lakshmi</given_name>
                    <surname>Yatham</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Heinz</given_name>
                    <surname>Grunze</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Eduard</given_name>
                    <surname>Vieta</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Allan</given_name>
                    <surname>Young</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Pierre</given_name>
                    <surname>Blier</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Siegfried</given_name>
                    <surname>Kasper</surname>
                  </person_name>
                  <person_name contributor_role="author" sequence="additional">
                    <given_name>Hans Jurgen</given_name>
                    <surname>Moeller</surname>
                  </person_name>
                </contributors>
                <publication_date media_type="online">
                  <month>11</month>
                  <day>05</day>
                  <year>2016</year>
                </publication_date>
                <pages>
                  <first_page>pyw100</first_page>
                </pages>
                <publisher_item>
                  <item_number item_number_type="pisa">ijnp;pyw100v2</item_number>
                  <identifier id_type="doi">10.1093/ijnp/pyw100</identifier>
                </publisher_item>
                <doi_data>
                  <doi>10.1093/ijnp/pyw100</doi>
                  <timestamp>2016122218201361000</timestamp>
                  <resource>https://academic.oup.com/ijnp/article-lookup/doi/10.1093/ijnp/pyw100</resource>
                  <collection property="crawler-based">
                    <item crawler="iParadigms">
                      <resource>http://academic.oup.com/ijnp/article-pdf/20/2/121/18132267/pyw100.pdf</resource>
                    </item>
                  </collection>
                </doi_data>
                <citation_list>
                  <citation key="2016122218201361000_pyw100v2.1">
                    <journal_title>Am Fam Physician</journal_title>
                    <volume>55</volume>
                    <first_page>1447</first_page>
                    <cYear>1997</cYear>
                    <article_title>Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.2">
                    <doi>10.4088/JCP.v69n1014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.3">
                    <unstructured_citation>(2009) NCT00329108 study results. In.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.4">
                    <doi>10.1097/00004583-199701000-00032</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.5">
                    <doi>10.1016/j.biopsych.2012.05.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.6">
                    <doi>10.1097/YCT.0b013e31824f8296</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.7">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Aberg-Wistedt</author>
                    <volume>66</volume>
                    <first_page>129</first_page>
                    <cYear>1982</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.1982.tb00921.x</doi>
                    <article_title>Comparison between zimelidine and desipramine in endogenous depression. A cross-over study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.8">
                    <doi>10.1097/YIC.0b013e3280c28410</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.9">
                    <doi>10.1159/000088445</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.10">
                    <unstructured_citation>Allen MH Currier GW Hughes DH Reyes-Harde M Docherty JP (2001) The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med:1–88; quiz 89–90.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.11">
                    <doi>10.1016/j.biopsych.2004.08.002</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.12">
                    <doi>10.1176/appi.ajp.163.2.313</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.13">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Altshuler</author>
                    <volume>70</volume>
                    <first_page>450</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.4088/JCP.08m04191</doi>
                    <article_title>Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.14">
                    <journal_title>J Psychopharmacol</journal_title>
                    <author>Amann</author>
                    <volume>10</volume>
                    <first_page>1289</first_page>
                    <cYear>2010</cYear>
                    <article_title>Lamotrigine: when and where does it act in affective disorders? A systematic review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.15">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Amrollahi</author>
                    <volume>129</volume>
                    <first_page>327</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1016/j.jad.2010.08.015</doi>
                    <article_title>Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.16">
                    <doi>10.1016/S0165-0327(99)00149-4</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.17">
                    <doi>10.1016/j.jad.2005.02.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.18">
                    <doi>10.1097/01.yic.0000171519.64080.c9</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.19">
                    <doi>10.1176/appi.ajp.2009.09020284</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.20">
                    <doi>10.1046/j.1399-5618.2003.00083.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.21">
                    <doi>10.1016/j.jad.2015.05.070</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.22">
                    <doi>10.1097/00004714-199812000-00003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.23">
                    <doi>10.1111/j.1399-5618.2011.00971.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.24">
                    <doi>10.1212/WNL.0b013e3181ea157e</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.25">
                    <doi>10.1016/S0165-0327(01)00377-9</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.26">
                    <doi>10.1159/000284227</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.27">
                    <journal_title>Am J Psychiatry</journal_title>
                    <volume>151</volume>
                    <first_page>1</first_page>
                    <cYear>1994</cYear>
                    <doi provider="crossref">10.1176/ajp.151.12.1</doi>
                    <article_title>Practice guideline for the treatment of patients with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.28">
                    <journal_title>Am Fam Physician</journal_title>
                    <volume>51</volume>
                    <first_page>1605</first_page>
                    <cYear>1995</cYear>
                    <article_title>American Psychiatric Association releases treatment guideline for bipolar disease</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.29">
                    <doi>10.1176/appi.ajp.159.1.1</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.30">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Arabzadeh</author>
                    <volume>17</volume>
                    <first_page>606</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1111/bdi.12324</doi>
                    <article_title>Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.31">
                    <doi>10.1056/NEJMoa0909801</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.32">
                    <doi>10.1186/1744-859X-4-5</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.33">
                    <doi>10.1016/j.jad.2012.07.013</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.34">
                    <doi>10.1016/S0140-6736(70)92870-9</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.35">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Bailine</author>
                    <volume>121</volume>
                    <first_page>431</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.2009.01493.x</doi>
                    <article_title>Electroconvulsive therapy is equally effective in unipolar and bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.36">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Baker</author>
                    <volume>4</volume>
                    <first_page>43</first_page>
                    <cYear>2002</cYear>
                    <doi provider="crossref">10.1034/j.1399-5618.2002.40103.x</doi>
                    <article_title>The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.37">
                    <doi>10.1097/00004714-200304000-00005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.38">
                    <doi>10.1192/bjp.185.6.472</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.39">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Baldessarini</author>
                    <volume>64</volume>
                    <first_page>44</first_page>
                    <cYear>2003</cYear>
                    <article_title>Lithium treatment and suicide risk in major affective disorders: update and new findings</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.40">
                    <doi>10.1097/01.jcp.0000085410.08426.9a</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.41">
                    <doi>10.4088/JCP.v67n0215</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.42">
                    <doi>10.1176/ajp.137.7.782</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.43">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Barnes</author>
                    <volume>174</volume>
                    <first_page>485</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1016/j.jad.2014.11.038</doi>
                    <article_title>A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.44">
                    <doi>10.1001/archpsyc.1975.01760270039003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.45">
                    <doi>10.1093/hrp/7.4.230</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.46">
                    <doi>10.1097/00004714-199904000-00012</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.47">
                    <journal_title>Molecular psychiatry</journal_title>
                    <author>Bauer</author>
                    <volume>21</volume>
                    <first_page>229</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1038/mp.2014.186</doi>
                    <article_title>Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.48">
                    <doi>10.1001/archpsyc.1990.01810170035006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.49">
                    <doi>10.1001/archpsyc.1990.01810170027005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.50">
                    <doi>10.4088/JCP.v60n0104</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.51">
                    <unstructured_citation>Baumhackl U Biziere K Fischbach R Geretsegger C Hebenstreit G Radmayr E Stabl M (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. The British journal of psychiatry Supplement:78–83.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.52">
                    <journal_title>Ann Clin Psychiatry</journal_title>
                    <author>Beaulieu</author>
                    <volume>24</volume>
                    <first_page>38</first_page>
                    <cYear>2012</cYear>
                    <article_title>The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.53">
                    <doi>10.1017/S1461145701002565</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.54">
                    <doi>10.2165/00023210-200216010-00004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.55">
                    <doi>10.1159/000093947</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.56">
                    <doi>10.1111/j.1600-0447.2009.01368.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.57">
                    <doi>10.4088/JCP.08m04772gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.58">
                    <doi>10.1097/00004850-199911000-00003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.59">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Berk</author>
                    <volume>76</volume>
                    <first_page>728</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.4088/JCP.13m08827</doi>
                    <article_title>Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.60">
                    <doi>10.1016/j.biopsych.2008.04.022</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.61">
                    <doi>10.1186/1741-7015-10-91</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.62">
                    <journal_title>Acta Neuropsychiatr</journal_title>
                    <author>Bernardo</author>
                    <volume>21</volume>
                    <first_page>285</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1601-5215.2009.00397.x</doi>
                    <article_title>Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.63">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Bersudsky</author>
                    <volume>12</volume>
                    <first_page>376</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2010.00828.x</doi>
                    <article_title>Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.64">
                    <doi>10.2165/00003088-198611030-00001</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.65">
                    <doi>10.1016/j.jad.2012.01.047</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.66">
                    <doi>10.1016/j.jad.2010.06.030</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.67">
                    <doi>10.1016/j.jad.2010.09.011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.68">
                    <doi>10.1177/0269881108093885</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.69">
                    <journal_title>Pharmacotherapy</journal_title>
                    <author>Blackburn</author>
                    <volume>18</volume>
                    <first_page>1277</first_page>
                    <cYear>1998</cYear>
                    <article_title>Antiepileptics and blood dyscrasias: A cohort study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.70">
                    <journal_title>Expert Rev Neurother</journal_title>
                    <author>Bobo</author>
                    <volume>10</volume>
                    <first_page>1637</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1586/ern.10.143</doi>
                    <article_title>Risperidone long-acting injecTable (Risperdal Consta(R)) for maintenance treatment in patients with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.71">
                    <doi>10.1111/j.1600-0447.1993.tb03487.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.72">
                    <doi>10.1016/j.jad.2009.11.008</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.73">
                    <doi>10.4088/JCP.v69n1009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.74">
                    <journal_title>Ann Clin Psychiatry</journal_title>
                    <author>Bond</author>
                    <volume>24</volume>
                    <first_page>23</first_page>
                    <cYear>2012</cYear>
                    <article_title>The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.75">
                    <doi>10.1111/bdi.12287</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.76">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Bora</author>
                    <volume>9</volume>
                    <first_page>468</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2007.00469.x</doi>
                    <article_title>The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.77">
                    <doi>10.1016/S0165-0327(00)00172-5</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.78">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Bottlender</author>
                    <volume>78</volume>
                    <first_page>149</first_page>
                    <cYear>2004</cYear>
                    <doi provider="crossref">10.1016/S0165-0327(02)00265-3</doi>
                    <article_title>Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.79">
                    <journal_title>International journal of bipolar disorders</journal_title>
                    <author>Bourin</author>
                    <volume>2</volume>
                    <first_page>14</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1186/s40345-014-0014-9</doi>
                    <article_title>Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.80">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Bowden</author>
                    <volume>66</volume>
                    <first_page>12</first_page>
                    <cYear>2005</cYear>
                    <article_title>Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.81">
                    <doi>10.4088/JCP.09m05482yel</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.82">
                    <doi>10.1038/sj.npp.1300788</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.83">
                    <doi>10.1111/j.1600-0447.2012.01890.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.84">
                    <doi>10.4088/JCP.v66n0116</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.85">
                    <doi>10.4088/JCP.v67n1003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.86">
                    <doi>10.1001/jama.1994.03510360044034</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.87">
                    <doi>10.1001/archpsyc.60.4.392</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.88">
                    <doi>10.1001/archpsyc.57.5.481</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.89">
                    <doi>10.1097/00004850-198907000-00005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.90">
                    <doi>10.1017/S1461145708009735</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.91">
                    <doi>10.4088/JCP.v67n0703</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.92">
                    <doi>10.4088/JCP.v69n0502</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.93">
                    <journal_title>Neuropsychopharmacology</journal_title>
                    <author>Brown</author>
                    <volume>39</volume>
                    <first_page>2867</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1038/npp.2014.138</doi>
                    <article_title>A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.94">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Brown</author>
                    <volume>172</volume>
                    <first_page>1014</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1176/appi.ajp.2015.14070857</doi>
                    <article_title>A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.95">
                    <doi>10.1016/j.pnpbp.2006.06.014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.96">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Burdick</author>
                    <volume>73</volume>
                    <first_page>103</first_page>
                    <cYear>2011</cYear>
                    <article_title>Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.97">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Burdick</author>
                    <volume>73</volume>
                    <first_page>103</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.4088/JCP.11m07299</doi>
                    <article_title>Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.98">
                    <doi provider="crossref">10.1002/14651858.CD003013</doi>
                    <unstructured_citation>Burgess S Geddes J Hawton K Townsend E Jamison K Goodwin G (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev:CD003013.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.99">
                    <doi>10.1016/S0924-977X(03)00079-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.100">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Calabrese</author>
                    <volume>75</volume>
                    <first_page>1054</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.4088/JCP.13m08951</doi>
                    <article_title>Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.101">
                    <doi>10.4088/JCP.v60n0203</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.102">
                    <doi>10.4088/JCP.09m05900gry</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.103">
                    <doi>10.1176/appi.ajp.162.11.2152</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.104">
                    <doi>10.1016/j.biopsych.2006.02.034</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.105">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Calabrese</author>
                    <volume>76</volume>
                    <first_page>284</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.4088/JCP.14m09081</doi>
                    <article_title>Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.106">
                    <doi>10.1176/appi.ajp.162.7.1351</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.107">
                    <doi>10.4088/JCP.v61n1106</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.108">
                    <doi>10.4088/JCP.v64n0906</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.109">
                    <journal_title>The Journal of nervous and mental disease</journal_title>
                    <author>Cardoso Tde</author>
                    <volume>203</volume>
                    <first_page>792</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1097/NMD.0000000000000369</doi>
                    <article_title>Biological Rhythm and Bipolar Disorder: Twelve-Month Follow-Up of a Randomized Clinical Trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.110">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Carlson</author>
                    <volume>14</volume>
                    <first_page>41</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2011.00974.x</doi>
                    <article_title>Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.111">
                    <journal_title>Neuropsychiatric disease and treatment</journal_title>
                    <author>Cazorla</author>
                    <volume>9</volume>
                    <first_page>409</first_page>
                    <cYear>2013</cYear>
                    <article_title>Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.112">
                    <doi>10.1186/1747-597X-2-29</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.113">
                    <journal_title>Psychoneuroendocrinology</journal_title>
                    <author>Cesta</author>
                    <volume>73</volume>
                    <first_page>196</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1016/j.psyneuen.2016.08.005</doi>
                    <article_title>Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.114">
                    <journal_title>Clin Ther</journal_title>
                    <author>Chapel</author>
                    <volume>38</volume>
                    <first_page>4</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1016/j.clinthera.2015.11.013</doi>
                    <article_title>Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.115">
                    <journal_title>Neuropsychiatric disease and treatment</journal_title>
                    <author>Chen</author>
                    <volume>9</volume>
                    <first_page>839</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.2147/NDT.S40503</doi>
                    <article_title>A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.116">
                    <doi>10.1034/j.1399-5618.2003.02237.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.117">
                    <doi>10.4088/JCP.v66n1219b</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.118">
                    <doi>10.1097/00004714-199912000-00003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.119">
                    <journal_title>Can J Psychiatry</journal_title>
                    <author>Chouinard</author>
                    <volume>38</volume>
                    <first_page>S114</first_page>
                    <cYear>1993</cYear>
                    <article_title>A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.120">
                    <doi>10.1111/j.1600-0447.1982.tb00852.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.121">
                    <journal_title>Cochrane Database Syst Rev</journal_title>
                    <author>Cipriani</author>
                    <volume>3</volume>
                    <first_page>CD004362</first_page>
                    <cYear>2006</cYear>
                    <article_title>Haloperidol alone or in combination for acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.122">
                    <doi>10.1177/0269881109106900</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.123">
                    <doi>10.1136/bmj.f3646</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.124">
                    <doi provider="crossref">10.1002/14651858.CD003492.pub2</doi>
                    <unstructured_citation>Cipriani A Smith K Burgess S Carney S Goodwin G Geddes J (2006b) Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev:CD003492.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.125">
                    <doi>10.1016/S0140-6736(11)60873-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.126">
                    <journal_title>Expert Rev Neurother</journal_title>
                    <author>Citrome</author>
                    <volume>10</volume>
                    <first_page>1031</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1586/ern.10.66</doi>
                    <article_title>Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.127">
                    <journal_title>Int J Clin Pract</journal_title>
                    <author>Citrome</author>
                    <volume>66</volume>
                    <first_page>318</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1111/j.1742-1241.2011.02890.x</doi>
                    <article_title>Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.128">
                    <doi>10.1016/j.jad.2013.10.040</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.129">
                    <journal_title>Int Clin Psychopharmacol</journal_title>
                    <author>Citrome</author>
                    <volume>31</volume>
                    <first_page>69</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1097/YIC.0000000000000106</doi>
                    <article_title>Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.130">
                    <doi>10.1097/00004850-198910000-00006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.131">
                    <journal_title>Journal of psychiatric practice</journal_title>
                    <author>Coley</author>
                    <volume>15</volume>
                    <first_page>150</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1097/01.pra.0000348369.19172.ba</doi>
                    <article_title>Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.132">
                    <journal_title>BrJPsychiatry</journal_title>
                    <author>Colom</author>
                    <volume>194</volume>
                    <first_page>260</first_page>
                    <cYear>2009</cYear>
                    <article_title>Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.133">
                    <journal_title>ArchGenPsychiatry</journal_title>
                    <author>Colom</author>
                    <volume>60</volume>
                    <first_page>402</first_page>
                    <cYear>2003</cYear>
                    <article_title>A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.134">
                    <journal_title>Acta Neuropsychiatrica</journal_title>
                    <author>Colom</author>
                    <volume>22</volume>
                    <first_page>50</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1111/j.1601-5215.2010.00450.x</doi>
                    <article_title>Has number of previous episodes any effect on respones to group psychoeducation in bipolar patients?</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.135">
                    <doi>10.1001/archpsyc.1982.04290050057011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.136">
                    <doi>10.1111/j.1600-0447.1981.tb00797.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.137">
                    <doi>10.1097/YIC.0b013e3280119dfb</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.138">
                    <doi>10.1001/archpsyc.1972.01750210042009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.139">
                    <doi>10.4088/JCP.13r08851</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.140">
                    <doi>10.1111/j.1399-5618.2010.00798.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.141">
                    <journal_title>Revista brasileira de psiquiatria</journal_title>
                    <author>Costa</author>
                    <volume>33</volume>
                    <first_page>144</first_page>
                    <cYear>2011</cYear>
                    <doi provider="crossref">10.1590/S1516-44462011000200009</doi>
                    <article_title>The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.142">
                    <doi>10.1001/archpsyc.1983.01790040068010</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.143">
                    <doi>10.1111/j.1600-0447.1992.tb01453.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.144">
                    <doi>10.1017/S1461145709990344</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.145">
                    <doi>10.1017/S0033291700042616</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.146">
                    <journal_title>Clin Ther</journal_title>
                    <author>Cutler</author>
                    <volume>33</volume>
                    <first_page>1643</first_page>
                    <cYear>2011</cYear>
                    <doi provider="crossref">10.1016/j.clinthera.2011.10.002</doi>
                    <article_title>Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.147">
                    <doi>10.1016/j.jad.2009.03.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.148">
                    <doi>10.1034/j.1399-5618.2001.030208.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.149">
                    <doi>10.1192/bjp.166.3.378</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.150">
                    <journal_title>Psychiatry Res</journal_title>
                    <author>Dauphinais</author>
                    <volume>196</volume>
                    <first_page>57</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1016/j.psychres.2012.01.015</doi>
                    <article_title>Controlled trial of safety and efficacy of bright light therapy vs negative air ions in patients with bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.151">
                    <doi>10.1111/j.1600-0447.1999.tb10890.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.152">
                    <doi>10.1016/j.jad.2004.09.009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.153">
                    <journal_title>Acta PsychiatrScand</journal_title>
                    <author>de Barros</author>
                    <volume>127</volume>
                    <first_page>153</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1111/acps.12007</doi>
                    <article_title>Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.154">
                    <doi>10.1177/0269881111408461</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.155">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>de Vries</author>
                    <volume>15</volume>
                    <first_page>645</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1111/bdi.12105</doi>
                    <article_title>The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.156">
                    <doi>10.1111/j.1440-1819.2012.02392.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.157">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Dell’Osso</author>
                    <volume>11</volume>
                    <first_page>76</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2008.00651.x</doi>
                    <article_title>Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.158">
                    <doi>10.4088/JCP.v58n1102</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.159">
                    <doi>10.1007/s11920-000-0074-7</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.160">
                    <doi>10.1016/j.jad.2014.10.053</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.161">
                    <doi>10.1037/1064-1297.15.6.569</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.162">
                    <doi>10.1001/archgenpsychiatry.2010.90</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.163">
                    <doi>10.1111/j.1399-5618.2012.00997.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.164">
                    <doi>10.1176/ajp.135.5.552</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.165">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Dube</author>
                    <volume>9</volume>
                    <first_page>618</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2007.00491.x</doi>
                    <article_title>Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.166">
                    <doi>10.1001/archpsyc.1976.01770010073014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.167">
                    <doi>10.1111/bdi.12238</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.168">
                    <doi>10.1176/appi.ajp.2015.15020164</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.169">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Eden Evins</author>
                    <volume>8</volume>
                    <first_page>75</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2006.00243.x</doi>
                    <article_title>A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.170">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Eden Evins</author>
                    <volume>8</volume>
                    <first_page>168</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2006.00303.x</doi>
                    <article_title>Inositol augmentation of lithium or valproate for bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.171">
                    <journal_title>J Affect Disord</journal_title>
                    <author>El-Mallakh</author>
                    <volume>136</volume>
                    <first_page>258</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1016/j.jad.2011.11.043</doi>
                    <article_title>A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.172">
                    <doi>10.1016/j.jad.2008.03.025</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.173">
                    <doi>10.1016/j.jad.2015.04.054</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.174">
                    <doi>10.1016/j.euroneuro.2010.07.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.175">
                    <doi>10.1016/0924-977X(96)00029-6</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.176">
                    <doi>10.1176/ajp.138.2.256</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.177">
                    <journal_title>Archiv Psychiatrie Nervenkrankheiten</journal_title>
                    <author>Emrich</author>
                    <volume>229</volume>
                    <first_page>1</first_page>
                    <cYear>1980</cYear>
                    <doi provider="crossref">10.1007/BF00343800</doi>
                    <article_title>Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.178">
                    <doi>10.1097/01.yic.0000224797.74771.be</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.179">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Engelsmann</author>
                    <volume>8</volume>
                    <first_page>207</first_page>
                    <cYear>1988</cYear>
                    <doi provider="crossref">10.1097/00004714-198806000-00011</doi>
                    <article_title>Lithium and memory: a long-term follow-up study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.180">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Fan</author>
                    <volume>14</volume>
                    <first_page>206</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2012.01001.x</doi>
                    <article_title>Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.181">
                    <unstructured_citation>FDA (2008) statistical review and evaluation: antiepileptic drugs and suicidality. Available online http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.182">
                    <doi>10.1176/ajp.133.8.925</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.183">
                    <doi>10.1097/01.chi.0000155981.83865.ea</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.184">
                    <doi>10.1007/s00213-014-3664-5</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.185">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_18</doi>
                    <unstructured_citation>Fountoulakis K (2015a) Treatment guidelines. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 643–658. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.186">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_16</doi>
                    <unstructured_citation>Fountoulakis K (2015b) Biological therapies. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 461–625. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.187">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_17</doi>
                    <unstructured_citation>Fountoulakis K (2015c) Psychosocial Treatment and interventions. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 627–642. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.188">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_11</doi>
                    <unstructured_citation>Fountoulakis K (2015d) Classification and epidemiology. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 341–360. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.189">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_10</doi>
                    <unstructured_citation>Fountoulakis K (2015e) Comorbidity. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 225–340. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.190">
                    <unstructured_citation>Fountoulakis K (2015f) Personality Disorders (narcissistic, antisocial, borderline). In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 197–204. Sp Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.191">
                    <doi provider="crossref">10.1007/978-3-642-37216-2_9</doi>
                    <unstructured_citation>Fountoulakis K (2015g) Alcohol and substance use in BD patients. In: Bipolar disorder: an evidence-based guide to manic depression ( Fountoulakis K , ed), pp 205–223. Berlin Heidelberg: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.192">
                    <doi>10.1017/S1092852900013894</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.193">
                    <journal_title>CNS Neurosci Ther</journal_title>
                    <author>Fountoulakis</author>
                    <volume>18</volume>
                    <first_page>227</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1111/j.1755-5949.2011.00259.x</doi>
                    <article_title>Refractoriness in bipolar disorder: definitions and evidence-based treatment</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.194">
                    <doi>10.1017/S1461145708009231</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.195">
                    <doi>10.1038/npp.2011.234</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.196">
                    <journal_title>Lancet</journal_title>
                    <author>Fountoulakis</author>
                    <volume>379</volume>
                    <first_page>893</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1016/S0140-6736(12)60391-2</doi>
                    <article_title>Comparative efficacy of anti-manic drugs in acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.197">
                    <doi>10.1016/j.jad.2010.10.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.198">
                    <doi>10.1016/j.jad.2011.04.043</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.199">
                    <doi>10.1016/j.brainresrev.2008.04.005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.200">
                    <journal_title>Ann Gen Psychiatry</journal_title>
                    <author>Fountoulakis</author>
                    <volume>8</volume>
                    <first_page>27</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1186/1744-859X-8-27</doi>
                    <article_title>Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.201">
                    <doi>10.1016/j.jad.2008.06.014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.202">
                    <doi>10.1186/1744-859X-10-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.203">
                    <doi>10.1111/bdi.12045</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.204">
                    <doi>10.1017/S1461145711001817</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.205">
                    <doi>10.1016/j.jad.2005.01.004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.206">
                    <doi>10.1017/S1461145707007821</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.207">
                    <doi>10.1016/j.pnpbp.2007.11.006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.208">
                    <doi>10.1177/0269881112440514</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.209">
                    <journal_title>Eur Arch Psychiatry Clin Neurosci</journal_title>
                    <author>Fountoulakis</author>
                    <volume>262</volume>
                    <first_page>1</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1007/s00406-012-0323-x</doi>
                    <article_title>Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.210">
                    <journal_title>Int J Psychiatry Clin Pract</journal_title>
                    <author>Fountoulakis</author>
                    <volume>19</volume>
                    <first_page>158</first_page>
                    <cYear>2015</cYear>
                    <article_title>Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.211">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Frances</author>
                    <volume>57</volume>
                    <first_page>1</first_page>
                    <cYear>1996</cYear>
                    <article_title>The expert consensus guideline series: treatment of bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.212">
                    <doi>10.1192/bjp.188.1.46</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.213">
                    <doi>10.1177/0269881106067787</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.214">
                    <doi>10.1016/j.biopsych.2005.04.056</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.215">
                    <journal_title>AmJPsychiatry</journal_title>
                    <author>Frank</author>
                    <volume>165</volume>
                    <first_page>1559</first_page>
                    <cYear>2008</cYear>
                    <article_title>The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.216">
                    <journal_title>ArchGenPsychiatry</journal_title>
                    <author>Frank</author>
                    <volume>62</volume>
                    <first_page>996</first_page>
                    <cYear>2005</cYear>
                    <article_title>Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.217">
                    <doi>10.1176/ajp.149.1.108</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.218">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Frye</author>
                    <volume>67</volume>
                    <first_page>1721</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.4088/JCP.v67n1108</doi>
                    <article_title>Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.219">
                    <doi>10.4088/JCP.10123co1c</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.220">
                    <doi>10.1097/00004714-200012000-00004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.221">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Frye</author>
                    <volume>120</volume>
                    <first_page>10</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.2008.01343.x</doi>
                    <article_title>Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.222">
                    <doi>10.1176/appi.ajp.2007.06060981</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.223">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Fyro</author>
                    <volume>269</volume>
                    <first_page>17</first_page>
                    <cYear>1977</cYear>
                    <article_title>A double-blind study of the prophylactic effect of lithium in manic-depressive disease</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.224">
                    <doi>10.1517/14740338.2015.1053457</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.225">
                    <doi>10.4088/JCP.v66n1106</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.226">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Gao</author>
                    <volume>33</volume>
                    <first_page>425</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1097/JCP.0b013e3182917f3f</doi>
                    <article_title>Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.227">
                    <doi>10.4088/JCP.09r05535gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.228">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Gao</author>
                    <volume>75</volume>
                    <first_page>1062</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.4088/JCP.13m08847</doi>
                    <article_title>Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.229">
                    <doi>10.1016/0165-0327(80)90029-4</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.230">
                    <doi>10.1192/bjp.bp.107.048504</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.231">
                    <doi>10.1176/appi.ajp.161.2.217</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.232">
                    <doi>10.1016/S0140-6736(09)61828-6</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.233">
                    <doi>10.1016/0278-5846(92)90080-X</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.234">
                    <doi>10.1097/00004583-199802000-00009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.235">
                    <doi>10.1111/j.1600-0447.2008.01257.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.236">
                    <doi>10.1097/JCP.0b013e3181a497d7</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.237">
                    <doi>10.4088/JCP.v68n1203</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.238">
                    <doi>10.4088/JCP.08m04909gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.239">
                    <journal_title>Depression Res Treatment</journal_title>
                    <author>Ghanizadeh</author>
                    <volume>2014</volume>
                    <first_page>730505</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1155/2014/730505</doi>
                    <article_title>Lovastatin as an adjuvant to lithium for treating manic phase of bipolar disorder: a 4-week, randomized, double-blind, placebo-controlled clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.240">
                    <doi>10.1001/archgenpsychiatry.2009.159</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.241">
                    <doi>10.1176/appi.ajp.2007.07030454</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.242">
                    <doi>10.1176/appi.ajp.161.9.1537</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.243">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Gilbert</author>
                    <volume>59</volume>
                    <first_page>345</first_page>
                    <cYear>1998</cYear>
                    <doi provider="crossref">10.4088/JCP.v59n0702</doi>
                    <article_title>Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.244">
                    <journal_title>Eur Neuropsychopharmacol</journal_title>
                    <author>Goikolea</author>
                    <volume>23</volume>
                    <first_page>305</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1016/j.euroneuro.2012.05.017</doi>
                    <article_title>Faster onset of antimanic action with haloperidol compared with second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.245">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Goikolea</author>
                    <volume>144</volume>
                    <first_page>191</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1016/j.jad.2012.07.038</doi>
                    <article_title>Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.246">
                    <unstructured_citation>Goldberg J (2008) Adverse cognitive effects of psychotropic medications. In: Cognitive dysfunction in bipolar disorder: a guide for clinicians ( Goldberg J Burdick K , eds), pp 137–158. Washington, DC: American Psychiatric Press.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.247">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Goldberg</author>
                    <volume>61</volume>
                    <first_page>12</first_page>
                    <cYear>2000</cYear>
                    <article_title>Treatment guidelines: current and future management of bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.248">
                    <doi>10.1046/j.1399-5618.2003.00067.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.249">
                    <doi>10.1111/j.1399-5618.2009.00716.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.250">
                    <doi>10.2165/00003495-200363190-00009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.251">
                    <journal_title>PsychotherPsychosom</journal_title>
                    <author>Gomes</author>
                    <volume>80</volume>
                    <first_page>144</first_page>
                    <cYear>2011</cYear>
                    <article_title>A randomized controlled trial of cognitive behavioral group therapy for bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.252">
                    <journal_title>Curr Med Res Opin</journal_title>
                    <author>Gonzalez</author>
                    <volume>29</volume>
                    <first_page>241</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1185/03007995.2013.766591</doi>
                    <article_title>Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.253">
                    <journal_title>Eur Psychiatry</journal_title>
                    <author>Gonzalez Isasi</author>
                    <volume>29</volume>
                    <first_page>134</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1016/j.eurpsy.2012.11.002</doi>
                    <article_title>Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.254">
                    <doi>10.1001/archpsyc.1969.01740220102012</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.255">
                    <doi>10.1176/appi.ajp.129.1.44</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.256">
                    <doi>10.1001/jama.290.11.1467</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.257">
                    <journal_title>Int J Psychiatry Clin Pract</journal_title>
                    <author>Goodwin</author>
                    <volume>1</volume>
                    <first_page>S9</first_page>
                    <cYear>1997</cYear>
                    <doi provider="crossref">10.3109/13651509709024750</doi>
                    <article_title>Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.258">
                    <doi>10.1177/0269881103017002003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.259">
                    <doi>10.1177/0269881109102919</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.260">
                    <doi>10.4088/JCP.v65n0321</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.261">
                    <unstructured_citation>Goodwin GM . (2016) Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.262">
                    <doi>10.4088/JCP.v66n0809</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.263">
                    <unstructured_citation>Grande I Berk M Birmaher B Vieta E (2015) Bipolar disorder. Lancet.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.264">
                    <doi>10.1016/0022-3956(70)90004-X</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.265">
                    <doi>10.1097/00004850-199914050-00002</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.266">
                    <doi>10.1097/00004850-199914050-00003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.267">
                    <doi>10.1097/00004714-199812000-00007</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.268">
                    <doi>10.1016/S0165-0327(96)01427-9</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.269">
                    <doi>10.1016/S0165-0327(99)00041-5</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.270">
                    <doi>10.1080/15622970410029924</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.271">
                    <doi>10.1080/15622970902823202</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.272">
                    <doi>10.1016/j.jad.2014.11.013</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.273">
                    <doi>10.3109/15622970209150612</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.274">
                    <doi>10.1080/15622970310029920</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.275">
                    <doi>10.3109/15622970903555881</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.276">
                    <doi>10.3109/15622975.2013.770551</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.277">
                    <journal_title>CNS Spectr</journal_title>
                    <author>Grunze</author>
                    <volume>13</volume>
                    <first_page>790</first_page>
                    <cYear>2008</cYear>
                    <doi provider="crossref">10.1017/S1092852900013912</doi>
                    <article_title>Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.278">
                    <journal_title>Biol Psychiatry</journal_title>
                    <author>Gyulai</author>
                    <volume>53</volume>
                    <first_page>899</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.1016/S0006-3223(02)01573-1</doi>
                    <article_title>Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.279">
                    <doi>10.1038/sj.npp.1300190</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.280">
                    <journal_title>Isr J Psychiatry Relat Sci</journal_title>
                    <author>Harel</author>
                    <volume>45</volume>
                    <first_page>121</first_page>
                    <cYear>2008</cYear>
                    <article_title>Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.281">
                    <doi>10.4088/JCP.v64n0206</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.282">
                    <doi>10.1037/a0038655</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.283">
                    <doi>10.1159/000068691</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.284">
                    <journal_title>Epilepsia</journal_title>
                    <author>Hesdorffer</author>
                    <volume>50</volume>
                    <first_page>978</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1528-1167.2009.02012.x</doi>
                    <article_title>The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.285">
                    <journal_title>The Journal of nervous and mental disease</journal_title>
                    <author>Himmelhoch</author>
                    <volume>170</volume>
                    <first_page>628</first_page>
                    <cYear>1982</cYear>
                    <doi provider="crossref">10.1097/00005053-198210000-00007</doi>
                    <article_title>A double-blind study of tranylcypromine treatment of major anergic depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.286">
                    <doi>10.1176/ajp.148.7.910</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.287">
                    <unstructured_citation>Hirschfeld R (2005) Guideline Watch for the Practice Guideline for the Treatment of Patients With Bipolar Disorder. In. Arlington, VA: American Psychiatric Association.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.288">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Hirschfeld</author>
                    <volume>60</volume>
                    <first_page>815</first_page>
                    <cYear>1999</cYear>
                    <doi provider="crossref">10.4088/JCP.v60n1202</doi>
                    <article_title>Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.289">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Hirschfeld</author>
                    <volume>71</volume>
                    <first_page>426</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.4088/JCP.08m04960yel</doi>
                    <article_title>A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.290">
                    <doi>10.1176/appi.ajp.161.6.1057</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.291">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Holmes</author>
                    <volume>10</volume>
                    <first_page>806</first_page>
                    <cYear>2008</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2008.00628.x</doi>
                    <article_title>A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.292">
                    <doi>10.1097/00004850-199905002-00003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.293">
                    <doi>10.1371/journal.pmed.0050020</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.294">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Houston</author>
                    <volume>67</volume>
                    <first_page>1246</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.4088/JCP.v67n0811</doi>
                    <article_title>Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.295">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Houston</author>
                    <volume>70</volume>
                    <first_page>1540</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.4088/JCP.08m04895yel</doi>
                    <article_title>Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.296">
                    <doi>10.1016/j.jpsychires.2010.05.016</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.297">
                    <doi>10.1016/S0140-6736(72)91222-6</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.298">
                    <doi>10.1023/A:1009066725103</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.299">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Inder</author>
                    <volume>17</volume>
                    <first_page>128</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1111/bdi.12273</doi>
                    <article_title>Randomized, controlled trial of Interpersonal and Social Rhythm Therapy for young people with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.300">
                    <doi provider="crossref">10.1016/j.jad.2013.05.074</doi>
                    <unstructured_citation>Ives-Deliperi VL Howells F Stein DJ Meintjes EM Horn N (2013) The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: A controlled functional MRI investigation. JAffectDisord.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.301">
                    <journal_title>Eur Neuropsychopharmacol</journal_title>
                    <author>Jahangard</author>
                    <volume>24</volume>
                    <first_page>1210</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1016/j.euroneuro.2014.05.013</doi>
                    <article_title>In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.302">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Jamrozinski</author>
                    <volume>119</volume>
                    <first_page>365</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.2008.01320.x</doi>
                    <article_title>Neurocognitive functions in euthymic bipolar patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.303">
                    <doi>10.1176/ajp.155.7.972</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.304">
                    <doi provider="crossref">10.1016/S2215-0366(15)00545-3</doi>
                    <unstructured_citation>Jauhar S McKenna PJ Laws KR (2016) NICE guidance on psychological treatments for bipolar disorder: searching for the evidence. The lancet Psychiatry.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.305">
                    <journal_title>Biol Psychiatry</journal_title>
                    <author>Jimerson</author>
                    <volume>15</volume>
                    <first_page>45</first_page>
                    <cYear>1980</cYear>
                    <article_title>Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.306">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Joas</author>
                    <volume>17</volume>
                    <first_page>136</first_page>
                    <cYear>2015</cYear>
                    <article_title>Effectiveness of medication in preventing hospitalization of bipolar patients - a register based study of mood stabilizing medication with lithium and anticonvulsants in Sweden</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.307">
                    <journal_title>Int J Psychiatry Clin Pract</journal_title>
                    <author>Jobson</author>
                    <volume>1</volume>
                    <first_page>S3</first_page>
                    <cYear>1997</cYear>
                    <doi provider="crossref">10.3109/13651509709024748</doi>
                    <article_title>International Psychopharmacology Algorithm Project: Algorithms in psychopharmacology</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.308">
                    <journal_title>World J Biol Psychiatry</journal_title>
                    <author>Jon</author>
                    <volume>10</volume>
                    <first_page>846</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1080/15622970802144865</doi>
                    <article_title>Revised Korean medication algorithm for bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.309">
                    <doi>10.1016/j.pnpbp.2008.10.012</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.310">
                    <doi>10.1097/01.chi.0000129223.89433.74</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.311">
                    <doi>10.1016/j.eurpsy.2008.12.014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.312">
                    <journal_title>World J Biol Psychiatry</journal_title>
                    <author>Kanba</author>
                    <volume>15</volume>
                    <first_page>113</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.3109/15622975.2012.669047</doi>
                    <article_title>A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.313">
                    <doi>10.1001/archpsyc.1982.04290090053011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.314">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Kaptsan</author>
                    <volume>5</volume>
                    <first_page>36</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.1034/j.1399-5618.2003.00003.x</doi>
                    <article_title>Right prefrontal TMS versus sham treatment of mania: a controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.315">
                    <journal_title>Pharmacopsychiatry</journal_title>
                    <author>Kargar</author>
                    <volume>48</volume>
                    <first_page>268</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1055/s-0035-1559667</doi>
                    <article_title>Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.316">
                    <doi>10.1007/BF00426753</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.317">
                    <doi>10.1016/S0140-6736(72)92028-4</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.318">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Katagiri</author>
                    <volume>136</volume>
                    <first_page>476</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1016/j.jad.2011.10.045</doi>
                    <article_title>Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.319">
                    <journal_title>BMC Psychiatry</journal_title>
                    <author>Katagiri</author>
                    <volume>13</volume>
                    <first_page>138</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1186/1471-244X-13-138</doi>
                    <article_title>Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.320">
                    <doi>10.1016/j.jad.2008.05.014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.321">
                    <doi>10.1176/appi.ajp.160.4.741</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.322">
                    <doi>10.1176/appi.ajp.160.9.1651</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.323">
                    <doi>10.4088/JCP.v66n0511</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.324">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Keck</author>
                    <volume>67</volume>
                    <first_page>626</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.4088/JCP.v67n0414</doi>
                    <article_title>A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.325">
                    <doi>10.4088/JCP.v68n1003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.326">
                    <doi>10.1016/j.biopsych.2006.03.056</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.327">
                    <doi>10.4088/JCP.07m04022</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.328">
                    <doi>10.1016/j.euroneuro.2011.06.005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.329">
                    <doi>10.1111/bdi.12013</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.330">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Kemp</author>
                    <volume>130</volume>
                    <first_page>171</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1016/j.jad.2010.10.026</doi>
                    <article_title>Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.331">
                    <journal_title>The Medical journal of Australia</journal_title>
                    <author>Kessell</author>
                    <volume>1</volume>
                    <first_page>773</first_page>
                    <cYear>1975</cYear>
                    <article_title>A controlled study of a tetracyclic antidepressant--maprotiline (Ludiomil)</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.332">
                    <doi>10.1017/S0033291798006862</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.333">
                    <journal_title>BMC Psychiatry</journal_title>
                    <author>Kessler</author>
                    <volume>10</volume>
                    <first_page>16</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1186/1471-244X-10-16</doi>
                    <article_title>The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.334">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Kessler</author>
                    <volume>75</volume>
                    <first_page>e1306</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.4088/JCP.13m08960</doi>
                    <article_title>The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.335">
                    <doi>10.1016/j.jad.2015.04.012</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.336">
                    <journal_title>J Psychiatr Res</journal_title>
                    <author>Ketter</author>
                    <volume>44</volume>
                    <first_page>8</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1016/j.jpsychires.2009.07.006</doi>
                    <article_title>Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.337">
                    <doi>10.4088/JCP.v67n0113</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.338">
                    <doi>10.1001/archpsyc.57.4.311</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.339">
                    <doi>10.1017/S1461145701002322</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.340">
                    <doi>10.1176/appi.ajp.160.4.790</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.341">
                    <doi>10.1192/bjp.187.3.229</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.342">
                    <journal_title>Acta Psychiatr Scand Suppl</journal_title>
                    <author>King</author>
                    <volume>380</volume>
                    <first_page>53</first_page>
                    <cYear>1994</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.1994.tb05833.x</doi>
                    <article_title>Psychomotor impairment and cognitive disturbances induced by neuroleptics</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.343">
                    <doi>10.1001/archpsyc.1967.01730190120016</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.344">
                    <doi>10.1001/archpsyc.1984.01790130061009</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.345">
                    <doi>10.1192/bjp.139.3.255</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.346">
                    <doi>10.1159/000054844</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.347">
                    <doi>10.1017/S0033291702005251</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.348">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Kocsis</author>
                    <volume>13</volume>
                    <first_page>268</first_page>
                    <cYear>1993</cYear>
                    <doi provider="crossref">10.1097/00004714-199308000-00007</doi>
                    <article_title>Neuropsychologic effects of lithium discontinuation</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.349">
                    <doi>10.1111/j.1600-0447.1979.tb06951.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.350">
                    <doi>10.1016/j.psyneuen.2005.11.001</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.351">
                    <doi>10.1016/j.psyneuen.2014.02.004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.352">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Kupka</author>
                    <volume>64</volume>
                    <first_page>1483</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.4088/JCP.v64n1213</doi>
                    <article_title>Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.353">
                    <doi>10.1111/j.1399-5618.2006.00276.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.354">
                    <unstructured_citation>Kusumakar V Yatham L Parikh S (1997) Bipolar disorder: a summary of clinical issues and treatment options. In. Halifax, Nova Scotia: CANMAT Monograph.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.355">
                    <doi>10.1111/j.1399-5618.2011.00975.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.356">
                    <journal_title>JAffectDisord</journal_title>
                    <author>Lahera</author>
                    <volume>146</volume>
                    <first_page>132</first_page>
                    <cYear>2013</cYear>
                    <article_title>Social cognition and interaction training (SCIT) for outpatients with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.357">
                    <doi>10.1176/appi.ajp.2007.06122018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.358">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Landbloom</author>
                    <volume>190</volume>
                    <first_page>103</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1016/j.jad.2015.06.059</doi>
                    <article_title>Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.359">
                    <journal_title>Pharmacotherapy</journal_title>
                    <author>Lea</author>
                    <volume>27</volume>
                    <first_page>1339</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.1592/phco.27.9.1339</doi>
                    <article_title>Agitation associated with aripiprazole initiation</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.360">
                    <doi>10.1016/j.eurpsy.2007.01.1218</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.361">
                    <doi>10.1016/j.genhosppsych.2015.01.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.362">
                    <doi>10.1017/S1461145713000825</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.363">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Lee</author>
                    <volume>34</volume>
                    <first_page>337</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1097/JCP.0000000000000109</doi>
                    <article_title>The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.364">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Lenox</author>
                    <volume>53</volume>
                    <first_page>47</first_page>
                    <cYear>1992</cYear>
                    <article_title>Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.365">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Leon</author>
                    <volume>156</volume>
                    <first_page>195</first_page>
                    <cYear>1999</cYear>
                    <article_title>Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.366">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Lerer</author>
                    <volume>48</volume>
                    <first_page>89</first_page>
                    <cYear>1987</cYear>
                    <article_title>Carbamazepine versus lithium in mania: a double-blind study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.367">
                    <doi>10.1176/appi.ajp.163.2.232</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.368">
                    <doi>10.1185/030079908X253933</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.369">
                    <journal_title>Psychopharmacology (Berl)</journal_title>
                    <author>Li</author>
                    <volume>233</volume>
                    <first_page>1289</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1007/s00213-016-4215-z</doi>
                    <article_title>Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.370">
                    <doi>10.1176/appi.ajp.164.6.884</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.371">
                    <doi>10.1136/bmj.b2700</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.372">
                    <doi>10.1111/j.1600-0447.2008.01237.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.373">
                    <doi>10.1034/j.1600-0447.108.s419.1.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.374">
                    <journal_title>BrJPsychiatry</journal_title>
                    <author>Lobban</author>
                    <volume>196</volume>
                    <first_page>59</first_page>
                    <cYear>2010</cYear>
                    <article_title>Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.375">
                    <doi>10.1176/appi.ajp.2013.13070984</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.376">
                    <doi>10.1176/appi.ajp.2013.13070985</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.377">
                    <doi>10.1097/JCP.0b013e31825ccde5</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.378">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Loo</author>
                    <volume>132</volume>
                    <first_page>1</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1016/j.jad.2010.08.017</doi>
                    <article_title>Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.379">
                    <doi provider="crossref">10.1111/acps.12557</doi>
                    <unstructured_citation>Lorenzo-Luaces L Amsterdam JD Soeller I DeRubeis RJ (2016) Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Acta Psychiatr Scand.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.380">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Lund</author>
                    <volume>65</volume>
                    <first_page>233</first_page>
                    <cYear>1982</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.1982.tb00843.x</doi>
                    <article_title>Long-term lithium treatment and psychological functions</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.381">
                    <doi>10.1176/appi.ajp.159.6.909</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.382">
                    <doi>10.1192/bjp.153.2.198</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.383">
                    <doi>10.4088/PCC.08m00659</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.384">
                    <doi>10.1055/s-2007-1014662</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.385">
                    <doi>10.1111/j.1399-5618.2009.00761.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.386">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Machado-Vieira</author>
                    <volume>69</volume>
                    <first_page>1237</first_page>
                    <cYear>2008</cYear>
                    <doi provider="crossref">10.4088/JCP.v69n0806</doi>
                    <article_title>A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.387">
                    <doi provider="crossref">10.1002/14651858.CD004052</doi>
                    <unstructured_citation>Macritchie K Geddes JR Scott J Haslam D de Lima M Goodwin G (2003) Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev:CD004052.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.388">
                    <doi provider="crossref">10.1002/14651858.CD003196</doi>
                    <unstructured_citation>Macritchie KA Geddes JR Scott J Haslam DR Goodwin GM (2001) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev:CD003196.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.389">
                    <doi>10.1590/S1516-44462011000400011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.390">
                    <doi>10.1016/j.jad.2010.08.001</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.391">
                    <doi>10.1177/0004867413481631</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.392">
                    <doi>10.1111/j.1399-5618.2011.00918.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.393">
                    <doi>10.1177/0004867415617657</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.394">
                    <doi>10.1016/S0140-6736(88)92947-9</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.395">
                    <doi>10.1111/j.1399-5618.2011.00898.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.396">
                    <doi>10.1192/bjp.141.4.407</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.397">
                    <journal_title>ClinPractEpidemiolMentHealth</journal_title>
                    <author>Martinez-Aran</author>
                    <volume>7</volume>
                    <first_page>112</first_page>
                    <cYear>2011</cYear>
                    <article_title>Functional remediation for bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.398">
                    <doi>10.1097/00004583-199710001-00010</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.399">
                    <journal_title>The Journal of nervous and mental disease</journal_title>
                    <author>McClure</author>
                    <volume>203</volume>
                    <first_page>827</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1097/NMD.0000000000000378</doi>
                    <article_title>A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.400">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>McElroy</author>
                    <volume>50</volume>
                    <first_page>23</first_page>
                    <cYear>1989</cYear>
                    <article_title>Valproate in psychiatric disorders: literature review and clinical guidelines</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.401">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>McElroy</author>
                    <volume>57</volume>
                    <first_page>142</first_page>
                    <cYear>1996</cYear>
                    <article_title>A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.402">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>McElroy</author>
                    <volume>71</volume>
                    <first_page>557</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.4088/JCP.08m04854yel</doi>
                    <article_title>Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.403">
                    <doi>10.1097/YIC.0000000000000051</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.404">
                    <journal_title>Int Clin Psychopharmacol</journal_title>
                    <author>McElroy</author>
                    <volume>26</volume>
                    <first_page>48</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1097/YIC.0b013e3283400d35</doi>
                    <article_title>A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.405">
                    <doi>10.4088/JCP.08m04942gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.406">
                    <unstructured_citation>McGirr A Berlim MT Bond DJ Fleck MP Yatham LN Lam RW (2014) A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med:1–12.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.407">
                    <doi>10.1016/j.euroneuro.2005.02.006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.408">
                    <doi>10.1016/j.jad.2013.04.025</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.409">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>McIntyre</author>
                    <volume>76</volume>
                    <first_page>398</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.4088/JCP.14m09410</doi>
                    <article_title>Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.410">
                    <doi>10.1111/j.1399-5618.2009.00748.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.411">
                    <doi>10.1016/j.jad.2010.04.005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.412">
                    <doi>10.1016/j.jad.2009.12.028</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.413">
                    <doi>10.1111/bdi.12006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.414">
                    <doi>10.1517/14656560903448837</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.415">
                    <journal_title>Ann Clin Psychiatry</journal_title>
                    <author>McIntyre</author>
                    <volume>24</volume>
                    <first_page>69</first_page>
                    <cYear>2012</cYear>
                    <article_title>The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.416">
                    <doi>10.1016/j.jad.2009.01.014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.417">
                    <doi>10.1097/00004714-200108000-00006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.418">
                    <doi>10.1192/bjp.116.535.621</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.419">
                    <doi>10.1176/ajp.133.4.373</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.420">
                    <journal_title>PsycholMed</journal_title>
                    <author>Meyer</author>
                    <volume>42</volume>
                    <first_page>1429</first_page>
                    <cYear>2012</cYear>
                    <article_title>Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.421">
                    <doi>10.1185/03007995.2013.874988</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.422">
                    <journal_title>ArchGenPsychiatry</journal_title>
                    <author>Miklowitz</author>
                    <volume>60</volume>
                    <first_page>904</first_page>
                    <cYear>2003</cYear>
                    <article_title>A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.423">
                    <doi>10.1016/S0006-3223(00)00931-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.424">
                    <journal_title>ArchGenPsychiatry</journal_title>
                    <author>Miklowitz</author>
                    <volume>64</volume>
                    <first_page>419</first_page>
                    <cYear>2007</cYear>
                    <article_title>Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.425">
                    <journal_title>AmJPsychiatry</journal_title>
                    <author>Miklowitz</author>
                    <volume>164</volume>
                    <first_page>1340</first_page>
                    <cYear>2007</cYear>
                    <article_title>Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.426">
                    <doi>10.1046/j.1399-5618.2003.00070.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.427">
                    <doi>10.1176/appi.ajp.157.3.463</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.428">
                    <journal_title>Annals of general psychiatry</journal_title>
                    <author>Miziou</author>
                    <volume>14</volume>
                    <first_page>19</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1186/s12991-015-0057-z</doi>
                    <article_title>Psychosocial treatment and interventions for bipolar disorder: a systematic review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.429">
                    <journal_title>Harv Rev Psychiatry</journal_title>
                    <author>Mohammad</author>
                    <volume>22</volume>
                    <first_page>274</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1097/HRP.0000000000000018</doi>
                    <article_title>The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.430">
                    <doi>10.1136/bmj.b2535</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.431">
                    <doi>10.1016/S0924-977X(00)00140-1</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.432">
                    <journal_title>Global journal of health science</journal_title>
                    <author>Moosavi</author>
                    <volume>6</volume>
                    <first_page>36424</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.5539/gjhs.v6n6p163</doi>
                    <article_title>Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.433">
                    <doi>10.1002/hup.2369</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.434">
                    <doi>10.1016/j.yebeh.2007.04.008</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.435">
                    <doi>10.1097/00004714-200004000-00012</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.436">
                    <doi>10.1016/j.jad.2013.04.032</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.437">
                    <doi>10.1097/JCP.0b013e318266854c</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.438">
                    <journal_title>Curr Psychiatry Rep</journal_title>
                    <author>Murru</author>
                    <volume>17</volume>
                    <first_page>603</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1007/s11920-015-0603-z</doi>
                    <article_title>Management of adverse effects of mood stabilizers</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.439">
                    <doi>10.1111/j.1742-1241.2008.01735.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.440">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Muzina</author>
                    <volume>72</volume>
                    <first_page>813</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.4088/JCP.09m05570gre</doi>
                    <article_title>Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.441">
                    <doi>10.1034/j.1399-5618.2003.00011.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.442">
                    <unstructured_citation>National Collaborating Centre for Mental Health (2006) Bipolar disorder.The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38 NICE Guideline.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.443">
                    <doi>10.4088/JCP.v69n0808</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.444">
                    <doi>10.1176/appi.ajp.158.6.906</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.445">
                    <doi>10.1002/hup.912</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.446">
                    <doi>10.1111/j.1399-5618.2009.00737.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.447">
                    <unstructured_citation>NHS U (2014) Antidepressants - Side effects In.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.448">
                    <unstructured_citation>NICE (2014) Bipolar disorder. In.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.449">
                    <journal_title>Int Clin Psychopharmacol</journal_title>
                    <author>Nierenberg</author>
                    <volume>30</volume>
                    <first_page>59</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1097/YIC.0000000000000058</doi>
                    <article_title>Predictors of placebo response in bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.450">
                    <doi>10.1046/j.1528-1157.2002.40001.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.451">
                    <doi>10.1016/j.jad.2007.04.020</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.452">
                    <doi>10.1016/j.jad.2010.05.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.453">
                    <doi>10.1016/j.jad.2011.10.015</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.454">
                    <unstructured_citation>Nolen W Kupka R Schulte P Knoppert-van der Klein E Honig A Reichart C (2008) Richtlijn bipolaire stoornissen. 2 ed. Utrecht: De Tijdstrom Uitgerverij BV.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.455">
                    <doi>10.1111/bdi.12027</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.456">
                    <doi>10.1016/j.jad.2012.06.023</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.457">
                    <journal_title>Diseases of the nervous system</journal_title>
                    <author>Noyes</author>
                    <volume>35</volume>
                    <first_page>573</first_page>
                    <cYear>1974</cYear>
                    <article_title>Lithium treatment of depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.458">
                    <doi>10.1016/0010-440X(74)90015-7</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.459">
                    <doi>10.1136/bmj.333.7561.220</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.460">
                    <doi>10.1007/s40263-014-0197-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.461">
                    <doi>10.1007/BF00428308</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.462">
                    <doi>10.1007/BF00431111</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.463">
                    <doi>10.1055/s-2007-1014497</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.464">
                    <journal_title>Pharmacoepidemiol Drug Saf</journal_title>
                    <author>Olesen</author>
                    <volume>19</volume>
                    <first_page>518</first_page>
                    <cYear>2010</cYear>
                    <article_title>Antiepileptic drugs and risk of suicide: a nationwide study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.465">
                    <doi>10.1007/s00213-002-1056-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.466">
                    <doi>10.1176/appi.ajp.2011.11010163</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.467">
                    <doi>10.1001/archpsyc.1989.01810100100021</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.468">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Ostacher</author>
                    <volume>75</volume>
                    <first_page>e1186</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.4088/JCP.14com09427</doi>
                    <article_title>When positive isn’t positive: the hopes and disappointments of clinical trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.469">
                    <unstructured_citation>Ostacher MJ Tandon R Suppes T (2015a) Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: a novel, practical, patient-centered guide for clinicians. J Clin Psychiatry.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.470">
                    <journal_title>International journal of bipolar disorders</journal_title>
                    <author>Ostacher</author>
                    <volume>3</volume>
                    <first_page>11</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1186/s40345-015-0026-0</doi>
                    <article_title>Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.471">
                    <journal_title>Acta PsychiatrScand</journal_title>
                    <author>Ostacher</author>
                    <volume>118</volume>
                    <first_page>49</first_page>
                    <cYear>2008</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.2008.01201.x</doi>
                    <article_title>Correlates of subjective and objective burden among caregivers of patients with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.472">
                    <doi>10.1176/appi.ajp.2013.13020185</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.473">
                    <journal_title>Clin Drug Investig</journal_title>
                    <author>Pae</author>
                    <volume>32</volume>
                    <first_page>747</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1007/s40261-012-0009-1</doi>
                    <article_title>Achieving and sustaining remission in bipolar I disorder with ziprasidone: a post hoc analysis of a 24-week, double-blind, placebo-controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.474">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Pan</author>
                    <volume>13</volume>
                    <first_page>365</first_page>
                    <cYear>2011</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2011.00931.x</doi>
                    <article_title>Visuospatial working memory deficits in remitted patients with bipolar disorder: susceptibility to the effects of GABAergic agonists</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.475">
                    <doi>10.1034/j.1399-5618.2000.20305.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.476">
                    <doi>10.1016/j.jad.2006.01.024</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.477">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Patkar</author>
                    <volume>35</volume>
                    <first_page>319</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1097/JCP.0000000000000323</doi>
                    <article_title>A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.478">
                    <doi>10.1001/jama.2010.410</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.479">
                    <doi>10.1176/ajp.143.5.652</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.480">
                    <journal_title>BehavResTher</journal_title>
                    <author>Perich</author>
                    <volume>51</volume>
                    <first_page>338</first_page>
                    <cYear>2013</cYear>
                    <article_title>The association between meditation practice and treatment outcome in Mindfulness-based Cognitive Therapy for bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.481">
                    <journal_title>Acta PsychiatrScand</journal_title>
                    <author>Perich</author>
                    <volume>127</volume>
                    <first_page>333</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1111/acps.12033</doi>
                    <article_title>A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.482">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Perlis</author>
                    <volume>67</volume>
                    <first_page>509</first_page>
                    <cYear>2006</cYear>
                    <doi provider="crossref">10.4088/JCP.v67n0401</doi>
                    <article_title>Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.483">
                    <doi>10.4088/JCP.v67n1112</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.484">
                    <doi>10.1001/archpsyc.64.6.689</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.485">
                    <doi>10.1159/000096363</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.486">
                    <doi>10.1136/bmj.318.7177.149</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.487">
                    <doi>10.1111/j.1600-0447.1972.tb04389.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.488">
                    <doi>10.4088/JCP.v63n1207</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.489">
                    <doi>10.1016/j.jad.2010.04.025</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.490">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Placidi</author>
                    <volume>47</volume>
                    <first_page>490</first_page>
                    <cYear>1986</cYear>
                    <article_title>The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.491">
                    <doi>10.1176/appi.ajp.127.3.351</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.492">
                    <doi>10.1001/archpsyc.1991.01810250064008</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.493">
                    <journal_title>Ann Gen Psychiatry</journal_title>
                    <author>Popovic</author>
                    <volume>14</volume>
                    <first_page>15</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1186/s12991-015-0053-3</doi>
                    <article_title>Revisiting loxapine: a systematic review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.494">
                    <journal_title>Psychopharmacology (Berl)</journal_title>
                    <author>Popovic</author>
                    <volume>213</volume>
                    <first_page>657</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1007/s00213-010-2056-8</doi>
                    <article_title>Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.495">
                    <doi>10.1176/ajp.149.12.1727</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.496">
                    <doi>10.1176/ajp.143.1.29</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.497">
                    <doi>10.1016/0165-1781(87)90064-3</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.498">
                    <doi>10.1001/archpsyc.1983.04390010083010</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.499">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Post</author>
                    <volume>3</volume>
                    <first_page>259</first_page>
                    <cYear>2001</cYear>
                    <doi provider="crossref">10.1034/j.1399-5618.2001.30505.x</doi>
                    <article_title>Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.500">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Post</author>
                    <volume>5</volume>
                    <first_page>396</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.1046/j.1399-5618.2003.00065.x</doi>
                    <article_title>A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.501">
                    <doi>10.1192/bjp.bp.105.013045</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.502">
                    <doi>10.1097/01.jcp.0000169068.34322.70</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.503">
                    <doi>10.1016/j.jad.2008.12.020</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.504">
                    <doi>10.1001/archpsyc.1972.01750200050011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.505">
                    <doi>10.1001/archpsyc.1973.04200030104017</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.506">
                    <doi>10.1001/archpsyc.1973.01750330035006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.507">
                    <doi>10.1001/archpsyc.1983.01790220086014</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.508">
                    <journal_title>J Am Geriatr Soc</journal_title>
                    <author>Pugh</author>
                    <volume>60</volume>
                    <first_page>2042</first_page>
                    <cYear>2012</cYear>
                    <article_title>Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.509">
                    <doi>10.1002/hup.1096</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.510">
                    <doi>10.1016/j.biopsych.2010.01.015</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.511">
                    <journal_title>International journal of bipolar disorders</journal_title>
                    <author>Rajagopalan</author>
                    <volume>4</volume>
                    <first_page>7</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1186/s40345-016-0049-1</doi>
                    <article_title>The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.512">
                    <journal_title>JConsult ClinPsychol</journal_title>
                    <author>Rea</author>
                    <volume>71</volume>
                    <first_page>482</first_page>
                    <cYear>2003</cYear>
                    <article_title>Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.513">
                    <doi>10.1016/j.jad.2013.12.017</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.514">
                    <journal_title>PsychotherPsychosom</journal_title>
                    <author>Reinares</author>
                    <volume>73</volume>
                    <first_page>312</first_page>
                    <cYear>2004</cYear>
                    <article_title>Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.515">
                    <journal_title>BipolarDisord</journal_title>
                    <author>Reinares</author>
                    <volume>10</volume>
                    <first_page>511</first_page>
                    <cYear>2008</cYear>
                    <article_title>Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.516">
                    <doi provider="crossref">10.1002/14651858.CD004040</doi>
                    <unstructured_citation>Rendell JM Gijsman HJ Keck P Goodwin GM Geddes JR (2003) Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev:CD004040.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.517">
                    <doi provider="crossref">10.1002/14651858.CD004043.pub2</doi>
                    <unstructured_citation>Rendell JM Gijsman HJ Bauer MS Goodwin GM Geddes GR (2006) Risperidone alone or in combination for acute mania. Cochrane Database Syst Rev:CD004043.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.518">
                    <doi>10.1007/BF00426919</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.519">
                    <journal_title>Clin Ther</journal_title>
                    <author>Riesenberg</author>
                    <volume>34</volume>
                    <first_page>2202</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.1016/j.clinthera.2012.09.002</doi>
                    <article_title>Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.520">
                    <doi>10.1016/j.jad.2006.04.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.521">
                    <journal_title>Int Clin Psychopharmacol</journal_title>
                    <author>Rihmer</author>
                    <volume>11</volume>
                    <first_page>203</first_page>
                    <cYear>1996</cYear>
                    <doi provider="crossref">10.1097/00004850-199609000-00008</doi>
                    <article_title>Antidepressant-induced hypomania in obsessive-compulsive disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.522">
                    <unstructured_citation>Robertson B Grunze H Versavel M Costa R Almeida L Soares-da-Silva P (2010) Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093–203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2–093) for acute manic episodes associated with biopolar I disorder. Bipolar Disord:46.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.523">
                    <doi>10.1016/j.psychres.2015.10.032</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.524">
                    <journal_title>CNS Neurosci Ther</journal_title>
                    <author>Rosa</author>
                    <volume>17</volume>
                    <first_page>167</first_page>
                    <cYear>2009</cYear>
                    <doi provider="crossref">10.1111/j.1755-5949.2009.00089.x</doi>
                    <article_title>Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.525">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Rosenblat</author>
                    <volume>18</volume>
                    <first_page>89</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1111/bdi.12373</doi>
                    <article_title>Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.526">
                    <journal_title>Ann Clin Psychiatry</journal_title>
                    <author>Rosenbluth</author>
                    <volume>24</volume>
                    <first_page>56</first_page>
                    <cYear>2012</cYear>
                    <article_title>The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.527">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Rouillon</author>
                    <volume>52</volume>
                    <first_page>423</first_page>
                    <cYear>1991</cYear>
                    <article_title>Prophylactic efficacy of maprotiline on unipolar depression relapse</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.528">
                    <doi>10.4088/JCP.v67n1105</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.529">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Rush</author>
                    <volume>64</volume>
                    <first_page>357</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.4088/JCP.v64n0402</doi>
                    <article_title>Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.530">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Rush</author>
                    <volume>60</volume>
                    <first_page>284</first_page>
                    <cYear>1999</cYear>
                    <doi provider="crossref">10.4088/JCP.v60n0503</doi>
                    <article_title>Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.531">
                    <doi>10.1111/j.1399-5618.2004.00115.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.532">
                    <doi>10.1177/0269881106059693</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.533">
                    <unstructured_citation>Sachs GS Printz DJ Kahn DA Carpenter D Docherty JP (2000) The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec No:1–104.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.534">
                    <doi>10.1176/appi.ajp.159.7.1146</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.535">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Sachs</author>
                    <volume>55</volume>
                    <first_page>391</first_page>
                    <cYear>1994</cYear>
                    <article_title>A double-blind trial of bupropion versus desipramine for bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.536">
                    <doi>10.4088/JCP.09m05934</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.537">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Sachs</author>
                    <volume>73</volume>
                    <first_page>1412</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.4088/JCP.11m07388</doi>
                    <article_title>Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.538">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Sachs</author>
                    <volume>73</volume>
                    <first_page>1420</first_page>
                    <cYear>2012</cYear>
                    <doi provider="crossref">10.4088/JCP.11m07389</doi>
                    <article_title>Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.539">
                    <unstructured_citation>Sachs GS Collins MA Altshuler LL Ketter TA Suppes T Rasgon NL Frye MA Wozniak P (2001) Divalproex sodium versus placebo in the treatment of bipolar depression. In: 40th Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.540">
                    <doi>10.1016/j.jad.2014.11.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.541">
                    <doi>10.1056/NEJMoa064135</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.542">
                    <doi>10.1016/j.jad.2014.05.015</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.543">
                    <doi>10.1212/01.WNL.0000152877.08088.87</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.544">
                    <doi>10.1001/archpsyc.62.1.37</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.545">
                    <journal_title>Addictive behaviors</journal_title>
                    <author>Salloum</author>
                    <volume>32</volume>
                    <first_page>410</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.1016/j.addbeh.2006.05.007</doi>
                    <article_title>Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.546">
                    <journal_title>CNS Drugs</journal_title>
                    <author>Sanford</author>
                    <volume>22</volume>
                    <first_page>335</first_page>
                    <cYear>2008</cYear>
                    <doi provider="crossref">10.2165/00023210-200822040-00005</doi>
                    <article_title>Intramuscular aripiprazole: a review of its use in the management of agitation in schizophrenia and bipolar I disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.547">
                    <doi>10.1007/s40263-015-0234-2</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.548">
                    <doi>10.1016/S0165-0327(02)00334-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.549">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Saricicek</author>
                    <volume>72</volume>
                    <first_page>744</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.4088/JCP.09m05659gre</doi>
                    <article_title>Lvetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.550">
                    <doi>10.4088/JCP.10r06710</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.551">
                    <journal_title>Neuropsychiatric disease and treatment</journal_title>
                    <author>Sayyaparaju</author>
                    <volume>10</volume>
                    <first_page>459</first_page>
                    <cYear>2014</cYear>
                    <article_title>When to start aripiprazole therapy in patients with bipolar mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.552">
                    <doi>10.1016/j.jad.2006.05.023</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.553">
                    <journal_title>Ann Clin Psychiatry</journal_title>
                    <author>Schaffer</author>
                    <volume>24</volume>
                    <first_page>6</first_page>
                    <cYear>2012</cYear>
                    <article_title>The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.554">
                    <doi>10.1001/archpsyc.64.4.442</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.555">
                    <doi provider="crossref">10.1176/appi.ajp.2007.05081484</doi>
                    <unstructured_citation>Schneck CD Miklowitz DJ Miyahara S Araga M Wisniewski S Gyulai L Allen MH Thase ME Sachs GS (2008) The Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD. Am J Psychiatry.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.556">
                    <doi>10.1176/appi.ajp.2014.13111517</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.557">
                    <doi>10.1016/j.euroneuro.2013.09.010</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.558">
                    <journal_title>BrJPsychiatry</journal_title>
                    <author>Scott</author>
                    <volume>188</volume>
                    <first_page>313</first_page>
                    <cYear>2006</cYear>
                    <article_title>Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.559">
                    <journal_title>Clin Neuropharmacol</journal_title>
                    <author>Segal</author>
                    <volume>21</volume>
                    <first_page>176</first_page>
                    <cYear>1998</cYear>
                    <article_title>Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.560">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Senturk</author>
                    <volume>9</volume>
                    <first_page>136</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2007.00481.x</doi>
                    <article_title>Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.561">
                    <journal_title>Clin Neuropharmacol</journal_title>
                    <author>Seo</author>
                    <volume>34</volume>
                    <first_page>39</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1097/WNF.0b013e3182055c07</doi>
                    <article_title>Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.562">
                    <journal_title>Clin Neuropharmacol</journal_title>
                    <author>Sepede</author>
                    <volume>37</volume>
                    <first_page>17</first_page>
                    <cYear>2014</cYear>
                    <article_title>Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.563">
                    <doi>10.1186/s40345-014-0015-8</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.564">
                    <doi>10.1016/j.jad.2009.08.013</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.565">
                    <doi>10.1176/ajp.143.9.1166</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.566">
                    <doi>10.1037/0021-843X.96.1.64</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.567">
                    <doi>10.1016/j.jad.2012.07.016</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.568">
                    <doi>10.1016/j.jad.2008.10.005</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.569">
                    <doi>10.4088/JCP.v65n1218</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.570">
                    <doi>10.1111/j.1530-0277.2009.01024.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.571">
                    <journal_title>Alcohol Clin Exp Res</journal_title>
                    <author>Sherwood Brown</author>
                    <volume>38</volume>
                    <first_page>2113</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1111/acer.12445</doi>
                    <article_title>A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.572">
                    <doi>10.1185/030079904125004493</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.573">
                    <doi>10.1016/S0149-2918(04)90013-6</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.574">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Sholomskas</author>
                    <volume>147</volume>
                    <first_page>1090</first_page>
                    <cYear>1990</cYear>
                    <doi provider="crossref">10.1176/ajp.147.8.1090</doi>
                    <article_title>Mania in a panic disorder patient treated with fluoxetine</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.575">
                    <doi>10.1001/archpsyc.1975.01760190036004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.576">
                    <journal_title>Harv Rev Psychiatry</journal_title>
                    <author>Siamouli</author>
                    <volume>22</volume>
                    <first_page>379</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1097/HRP.0000000000000039</doi>
                    <article_title>Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.577">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Sidor</author>
                    <volume>72</volume>
                    <first_page>156</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.4088/JCP.09r05385gre</doi>
                    <article_title>Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.578">
                    <doi>10.1007/s11920-012-0323-6</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.579">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Sienaert</author>
                    <volume>15</volume>
                    <first_page>61</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1111/bdi.12026</doi>
                    <article_title>Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.580">
                    <doi>10.1192/bjp.164.6.806</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.581">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Silva</author>
                    <volume>146</volume>
                    <first_page>310</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1016/j.jad.2012.11.001</doi>
                    <article_title>Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.582">
                    <doi>10.1034/j.1600-0447.2001.00240.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.583">
                    <doi>10.1016/0165-0327(93)90057-Q</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.584">
                    <doi>10.1176/appi.ajp.163.1.41</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.585">
                    <doi>10.1176/appi.ajp.127.11.1555</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.586">
                    <journal_title>Psychopharmacol Bull</journal_title>
                    <author>Small</author>
                    <volume>31</volume>
                    <first_page>265</first_page>
                    <cYear>1995</cYear>
                    <article_title>Lithium combined with carbamazepine or haloperidol in the treatment of mania</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.587">
                    <doi>10.1001/archpsyc.1991.01810340047006</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.588">
                    <doi>10.1111/j.1600-0447.2006.00912.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.589">
                    <doi>10.1016/j.jad.2009.10.033</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.590">
                    <doi>10.1016/j.euroneuro.2004.06.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.591">
                    <unstructured_citation>Sole B Bonnin CM Mayoral M Amann BL Torres I Gonzalez-Pinto A Jimenez E Crespo JM Colom F Tabares-Seisdedos R Reinares M Ayuso-Mateos JL Soria S Garcia-Portilla MP Ibanez A Vieta E Martinez-Aran A Torrent C , the CFRG (2014) Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.592">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Song</author>
                    <volume>17</volume>
                    <first_page>94</first_page>
                    <cYear>2015</cYear>
                    <article_title>Suicide risk in bipolar disorder during treatment with lithium and valproate</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.593">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Squire</author>
                    <volume>137</volume>
                    <first_page>1042</first_page>
                    <cYear>1980</cYear>
                    <doi provider="crossref">10.1176/ajp.137.9.1042</doi>
                    <article_title>Effects of lithium carbonate on memory and other cognitive functions</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.594">
                    <journal_title>Canadian journal of psychiatry</journal_title>
                    <author>Srisurapanont</author>
                    <volume>40</volume>
                    <first_page>533</first_page>
                    <cYear>1995</cYear>
                    <doi provider="crossref">10.1177/070674379504000906</doi>
                    <article_title>Treatment of acute bipolar depression: a review of the literature</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.595">
                    <doi>10.1016/j.jad.2009.06.023</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.596">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Steiner</author>
                    <volume>148</volume>
                    <first_page>1403</first_page>
                    <cYear>1991</cYear>
                    <doi provider="crossref">10.1176/ajp.148.10.1403b</doi>
                    <article_title>Fluoxetine-induced mania in a patient with obsessive-compulsive disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.597">
                    <doi>10.1016/S0140-6736(71)91886-1</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.598">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Stoll</author>
                    <volume>57</volume>
                    <first_page>356</first_page>
                    <cYear>1996</cYear>
                    <article_title>Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.599">
                    <doi>10.1001/archpsyc.56.5.407</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.600">
                    <doi provider="crossref">10.1007/978-1-4612-3524-8_115</doi>
                    <unstructured_citation>Stoll K Goncalves N Krober H Demisch K Bellaire W (1989) Use of Carbamazepine in affective illness. In: New directions in affective disorders ( Lerer G Gershon S , eds), pp 540–544. New York: Springer-Verlag.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.601">
                    <unstructured_citation>Suppes T Calabrese J Silva R (2013) Lurasidone adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study (PREVAIL 3). Neuropsychopharmacology 38:abstract no. W147.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.602">
                    <doi>10.1016/j.jad.2005.07.011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.603">
                    <doi>10.1080/15622970701317265</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.604">
                    <doi>10.1016/j.jad.2007.08.015</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.605">
                    <journal_title>Psychopharmacol Bull</journal_title>
                    <author>Suppes</author>
                    <volume>31</volume>
                    <first_page>469</first_page>
                    <cYear>1995</cYear>
                    <article_title>Algorithms for the treatment of bipolar manic-depressive illness</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.606">
                    <doi>10.1176/appi.ajp.2008.08020189</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.607">
                    <doi>10.1016/j.jad.2009.10.007</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.608">
                    <doi>10.4088/JCP.12m08297</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.609">
                    <unstructured_citation>Suppes T Silva R Cucchiaro J Mao Y Targum S Streicher C Pikalov A Loebel A (2015) Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study. Am J Psychiatry:appiajp201515060770.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.610">
                    <doi>10.4088/JCP.v62n0607</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.611">
                    <doi>10.4088/JCP.v63n0404</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.612">
                    <doi>10.4088/JCP.v64n0403</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.613">
                    <journal_title>Drug design, development and therapy</journal_title>
                    <author>Suttajit</author>
                    <volume>8</volume>
                    <first_page>827</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.2147/DDDT.S63779</doi>
                    <article_title>Quetiapine for acute bipolar depression: a systematic review and meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.614">
                    <doi>10.1001/archpsyc.1997.01830130041008</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.615">
                    <doi>10.4088/JCP.09r05192gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.616">
                    <journal_title>BipolarDisord</journal_title>
                    <author>Swartz</author>
                    <volume>14</volume>
                    <first_page>211</first_page>
                    <cYear>2012</cYear>
                    <article_title>A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.617">
                    <doi>10.1159/000341309</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.618">
                    <journal_title>The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions</journal_title>
                    <author>Sylvia</author>
                    <volume>25</volume>
                    <first_page>94</first_page>
                    <cYear>2016</cYear>
                    <article_title>A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.619">
                    <doi>10.1186/1471-244X-11-101</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.620">
                    <doi>10.1097/JCP.0b013e31823f872f</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.621">
                    <journal_title>J Psychiatr Res</journal_title>
                    <author>Tada</author>
                    <volume>68</volume>
                    <first_page>151</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1016/j.jpsychires.2015.06.015</doi>
                    <article_title>Antidepressant dose and treatment response in bipolar depression: reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.622">
                    <doi>10.1017/S1461145709991039</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.623">
                    <doi>10.1097/JCP.0b013e3181ad223f</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.624">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Tarr</author>
                    <volume>134</volume>
                    <first_page>14</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1016/j.jad.2010.11.009</doi>
                    <article_title>Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.625">
                    <doi>10.1111/j.1399-5618.2011.00904.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.626">
                    <doi>10.1176/ajp.149.2.195</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.627">
                    <doi>10.3109/13651501.2011.632680</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.628">
                    <doi>10.1097/01.jcp.0000248603.76231.b7</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.629">
                    <doi>10.1097/jcp.0b013e3181618eb4</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.630">
                    <journal_title>Curr Neuropharmacol</journal_title>
                    <author>Thomas</author>
                    <volume>13</volume>
                    <first_page>681</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.2174/1570159X13666150115220221</doi>
                    <article_title>The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: a meta-analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.631">
                    <doi>10.1016/j.jad.2013.01.022</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.632">
                    <doi>10.1176/ajp.152.3.413</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.633">
                    <doi>10.1016/j.jad.2008.11.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.634">
                    <doi>10.1016/j.jad.2014.04.003</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.635">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Tohen</author>
                    <volume>52</volume>
                    <first_page>496</first_page>
                    <cYear>1991</cYear>
                    <article_title>Thrombocytopenia associated with carbamazepine: a case series</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.636">
                    <doi>10.1192/bjp.bp.112.108357</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.637">
                    <doi>10.1176/appi.ajp.163.2.247</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.638">
                    <doi>10.1176/appi.ajp.159.6.1011</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.639">
                    <doi>10.1176/appi.ajp.160.7.1263</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.640">
                    <doi>10.1192/bjp.bp.107.041301</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.641">
                    <doi>10.1001/archpsyc.57.9.841</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.642">
                    <doi>10.1192/bjp.184.4.337</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.643">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Tohen</author>
                    <volume>156</volume>
                    <first_page>702</first_page>
                    <cYear>1999</cYear>
                    <article_title>Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.644">
                    <doi>10.1001/archpsyc.59.1.62</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.645">
                    <doi>10.1001/archpsyc.60.12.1218</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.646">
                    <doi>10.1001/archpsyc.60.11.1079</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.647">
                    <doi>10.4088/JCP.v69n1113</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.648">
                    <doi>10.1176/appi.ajp.162.7.1281</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.649">
                    <doi>10.1111/j.1399-5618.2011.00973.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.650">
                    <doi>10.1034/j.1600-0447.2001.00464.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.651">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Tondo</author>
                    <volume>108</volume>
                    <first_page>4</first_page>
                    <cYear>2003</cYear>
                    <doi provider="crossref">10.1034/j.1600-0447.2003.00126.x</doi>
                    <article_title>Rapid-cycling bipolar disorder: effects of long-term treatments</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.652">
                    <journal_title>Acta Psychiatr Scand</journal_title>
                    <author>Tondo</author>
                    <volume>121</volume>
                    <first_page>404</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1111/j.1600-0447.2009.01514.x</doi>
                    <article_title>Mania associated with antidepressant treatment: comprehensive meta-analytic review</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.653">
                    <journal_title>AmJPsychiatry</journal_title>
                    <author>Torrent</author>
                    <volume>170</volume>
                    <first_page>852</first_page>
                    <cYear>2013</cYear>
                    <article_title>Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.654">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Truman</author>
                    <volume>68</volume>
                    <first_page>1472</first_page>
                    <cYear>2007</cYear>
                    <doi provider="crossref">10.4088/JCP.v68n1002</doi>
                    <article_title>Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.655">
                    <doi>10.1371/journal.pmed.1000434</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.656">
                    <doi>10.1186/s12991-015-0081-z</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.657">
                    <doi>10.1111/j.1600-0447.2009.01537.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.658">
                    <doi>10.1111/j.1399-5618.2011.00887.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.659">
                    <doi>10.4088/JCP.08m04152</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.660">
                    <doi>10.1192/bjp.bp.108.057612</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.661">
                    <doi>10.1186/1741-7015-8-4</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.662">
                    <doi provider="crossref">10.1002/14651858.CD005171.pub2</doi>
                    <unstructured_citation>Vasudev A Macritchie K Watson S Geddes JR Young AH (2008) Oxcarbazepine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev:CD005171.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.663">
                    <journal_title>Cochrane Database Syst Rev</journal_title>
                    <author>Vasudev</author>
                    <volume>12</volume>
                    <first_page>CD004857</first_page>
                    <cYear>2011</cYear>
                    <article_title>Oxcarbazepine for acute affective episodes in bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.664">
                    <doi>10.1007/s002130000380</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.665">
                    <doi>10.1017/S1461145713000023</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.666">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Vazquez</author>
                    <volume>183</volume>
                    <first_page>258</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1016/j.jad.2015.05.016</doi>
                    <article_title>Efficacy and tolerability of treatments for bipolar depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.667">
                    <journal_title>Eur Neuropsychopharmacol</journal_title>
                    <author>Vazquez</author>
                    <volume>25</volume>
                    <first_page>1501</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1016/j.euroneuro.2015.07.013</doi>
                    <article_title>Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.668">
                    <journal_title>J Affect Disord</journal_title>
                    <author>Veronese</author>
                    <volume>197</volume>
                    <first_page>268</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1016/j.jad.2016.03.034</doi>
                    <article_title>Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.669">
                    <journal_title>World psychiatry: official journal of the World Psychiatric Association</journal_title>
                    <author>Vieta</author>
                    <volume>6</volume>
                    <first_page>27</first_page>
                    <cYear>2007</cYear>
                    <article_title>Psychiatry: from interest in conflicts to conflicts of interest</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.670">
                    <doi>10.1176/appi.ajp.2014.14070826</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.671">
                    <journal_title>Revista de psiquiatria y salud mental</journal_title>
                    <author>Vieta</author>
                    <volume>8</volume>
                    <first_page>117</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1016/j.rpsm.2015.03.003</doi>
                    <article_title>[Personalised medicine applied to mental health: Precision psychiatry]</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.672">
                    <journal_title>Am J Psychiatry</journal_title>
                    <author>Vieta</author>
                    <volume>149</volume>
                    <first_page>1282</first_page>
                    <cYear>1992</cYear>
                    <doi provider="crossref">10.1176/ajp.149.9.1282-a</doi>
                    <article_title>Antidepressant-induced mania in obsessive-compulsive disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.673">
                    <doi>10.1185/030079905X46340</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.674">
                    <doi>10.1111/j.1399-5618.2007.00479.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.675">
                    <doi>10.1016/j.jad.2008.06.001</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.676">
                    <doi>10.1177/0269881108099418</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.677">
                    <doi>10.4088/JCP.v63n0607</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.678">
                    <doi>10.1111/j.1399-5618.2010.00815.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.679">
                    <doi>10.1016/j.euroneuro.2012.03.004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.680">
                    <doi>10.4088/JCP.v67n0320</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.681">
                    <doi>10.1176/appi.ajp.2008.07101560</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.682">
                    <journal_title>`</journal_title>
                    <author>Vieta</author>
                    <volume>30</volume>
                    <first_page>579</first_page>
                    <cYear>2010</cYear>
                    <article_title>Treatment options for bipolar depression: a systematic review of randomized, controlled trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.683">
                    <doi>10.1017/S1461145711000885</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.684">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Vieta</author>
                    <volume>65</volume>
                    <first_page>1420</first_page>
                    <cYear>2004</cYear>
                    <doi provider="crossref">10.4088/JCP.v65n1019</doi>
                    <article_title>Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.685">
                    <doi>10.1192/bjp.187.3.235</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.686">
                    <doi>10.1017/S1461145708008596</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.687">
                    <doi>10.1176/appi.ajp.2014.13111501</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.688">
                    <doi>10.1007/s00213-014-3453-1</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.689">
                    <doi>10.1192/bjp.150.2.180</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.690">
                    <doi>10.1016/j.biopsych.2012.05.029</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.691">
                    <doi>10.1176/ajp.145.2.179</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.692">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Weiser</author>
                    <volume>16</volume>
                    <first_page>441</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.1111/bdi.12202</doi>
                    <article_title>Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.693">
                    <unstructured_citation>Weisler R Dunn J English P (2003) Adjunctive Ziprasidone for acute bipolar mania: randomized, placebo-controlled trial. In: 4th International Forum on Mood and Anxiety Disorders. Monte Carlo, Monaco.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.694">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Weisler</author>
                    <volume>65</volume>
                    <first_page>478</first_page>
                    <cYear>2004</cYear>
                    <doi provider="crossref">10.4088/JCP.v65n0405</doi>
                    <article_title>A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.695">
                    <doi>10.4088/JCP.11m06878</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.696">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Weisler</author>
                    <volume>66</volume>
                    <first_page>323</first_page>
                    <cYear>2005</cYear>
                    <doi provider="crossref">10.4088/JCP.v66n0308</doi>
                    <article_title>Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.697">
                    <doi>10.4088/JCP.v69n0510</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.698">
                    <doi>10.2165/00023210-200620030-00004</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.699">
                    <journal_title>J Clin Psychopharmacol</journal_title>
                    <author>Welten</author>
                    <volume>36</volume>
                    <first_page>71</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1097/JCP.0000000000000435</doi>
                    <article_title>Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.700">
                    <journal_title>Epilepsy Behav</journal_title>
                    <author>Wen</author>
                    <volume>19</volume>
                    <first_page>494</first_page>
                    <cYear>2011</cYear>
                    <doi provider="crossref">10.1016/j.yebeh.2010.08.030</doi>
                    <article_title>Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.701">
                    <journal_title>Compr Psychiatry</journal_title>
                    <author>White</author>
                    <volume>27</volume>
                    <first_page>211</first_page>
                    <cYear>1986</cYear>
                    <doi provider="crossref">10.1016/0010-440X(86)90042-8</doi>
                    <article_title>Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.702">
                    <doi>10.1016/S0140-6736(04)16043-1</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.703">
                    <journal_title>JAffectDisord</journal_title>
                    <author>Williams</author>
                    <volume>107</volume>
                    <first_page>275</first_page>
                    <cYear>2008</cYear>
                    <article_title>Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.704">
                    <doi>10.1002/hup.1240</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.705">
                    <journal_title>Neuropsychiatric disease and treatment</journal_title>
                    <author>Woo</author>
                    <volume>11</volume>
                    <first_page>493</first_page>
                    <cYear>2015</cYear>
                    <article_title>Korean Medication Algorithm Project for Bipolar Disorder: third revision</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.706">
                    <doi>10.1016/j.biopsych.2009.02.018</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.707">
                    <journal_title>Neural plasticity</journal_title>
                    <author>Xu</author>
                    <volume>2015</volume>
                    <first_page>858251</first_page>
                    <cYear>2015</cYear>
                    <doi provider="crossref">10.1155/2015/858251</doi>
                    <article_title>Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.708">
                    <journal_title>Neuropsychiatric disease and treatment</journal_title>
                    <author>Xu</author>
                    <volume>11</volume>
                    <first_page>1265</first_page>
                    <cYear>2015</cYear>
                    <article_title>Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.709">
                    <doi>10.1097/01.jcp.0000144887.66319.2f</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.710">
                    <doi>10.1192/bjp.182.2.141</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.711">
                    <doi>10.1097/YIC.0b013e328080ca57</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.712">
                    <journal_title>Can J Psychiatry</journal_title>
                    <author>Yatham</author>
                    <volume>42</volume>
                    <first_page>87S</first_page>
                    <cYear>1997</cYear>
                    <article_title>Bipolar depression: treatment options</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.713">
                    <doi>10.1016/j.jad.2012.11.042</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.714">
                    <doi>10.1192/bjp.bp.114.147587</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.715">
                    <doi>10.1111/j.1399-5618.2006.00432.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.716">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Yatham</author>
                    <volume>15</volume>
                    <first_page>58</first_page>
                    <cYear>2013</cYear>
                    <doi provider="crossref">10.1111/bdi.12038</doi>
                    <article_title>The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.717">
                    <doi>10.1111/j.1399-5618.2009.00672.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.718">
                    <journal_title>Bipolar Disord</journal_title>
                    <author>Yatham</author>
                    <volume>7</volume>
                    <first_page>5</first_page>
                    <cYear>2005</cYear>
                    <doi provider="crossref">10.1111/j.1399-5618.2005.00219.x</doi>
                    <article_title>Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.719">
                    <doi>10.1111/bdi.12025</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.720">
                    <journal_title>Molecular Psychiatry</journal_title>
                    <author>Yatham</author>
                    <volume>21</volume>
                    <first_page>1050</first_page>
                    <cYear>2016</cYear>
                    <doi provider="crossref">10.1038/mp.2015.158</doi>
                    <article_title>Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.721">
                    <doi>10.1111/j.1600-0447.2004.00437.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.722">
                    <journal_title>Neuropsychopharmacology</journal_title>
                    <author>Yildiz</author>
                    <volume>36</volume>
                    <first_page>375</first_page>
                    <cYear>2010</cYear>
                    <doi provider="crossref">10.1038/npp.2010.192</doi>
                    <article_title>Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.723">
                    <doi>10.1001/archgenpsychiatry.2007.43</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.724">
                    <unstructured_citation>Yildiz A Nikodem M Vieta E Correll CU Baldessarini RJ (2014) A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med:1–19.</unstructured_citation>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.725">
                    <doi>10.1017/S0033291714001305</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.726">
                    <journal_title>World J Biol Psychiatry</journal_title>
                    <author>Young</author>
                    <volume>15</volume>
                    <first_page>96</first_page>
                    <cYear>2014</cYear>
                    <doi provider="crossref">10.3109/15622975.2012.665177</doi>
                    <article_title>A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.727">
                    <doi>10.1192/bjp.bp.108.049965</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.728">
                    <doi>10.4088/JCP.08m04995gre</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.729">
                    <doi>10.1176/appi.ajp.157.8.1351</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.730">
                    <journal_title>J Clin Psychiatry</journal_title>
                    <author>Zajecka</author>
                    <volume>63</volume>
                    <first_page>1148</first_page>
                    <cYear>2002</cYear>
                    <doi provider="crossref">10.4088/JCP.v63n1210</doi>
                    <article_title>A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.731">
                    <doi>10.1176/appi.ajp.161.1.169</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.732">
                    <doi>10.1111/j.1399-5618.2007.00530.x</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.733">
                    <doi>10.1016/j.biopsych.2004.03.013</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.734">
                    <doi>10.1016/j.biopsych.2011.12.010</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.735">
                    <doi>10.1177/070674370805300709</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.736">
                    <doi>10.1002/da.22340</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.737">
                    <doi>10.1016/j.jpsychires.2005.06.002</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.738">
                    <journal_title>Curr Med Res Opin</journal_title>
                    <author>Zhu</author>
                    <volume>21</volume>
                    <first_page>555</first_page>
                    <cYear>2005</cYear>
                    <doi provider="crossref">10.1185/030079905X38259</doi>
                    <article_title>Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial</article_title>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.739">
                    <doi>10.1097/NRL.0b013e3181f79f37</doi>
                  </citation>
                  <citation key="2016122218201361000_pyw100v2.740">
                    <doi>10.1016/S0165-1781(01)00242-6</doi>
                  </citation>
                </citation_list>
              </journal_article>
            </journal>
          </crossref>
        </doi_record>
      </query>
    </body>
  </query_result>
</crossref_result>